Work

Supplementary Table S3 from Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer

Year: 2023

Type: supplementary-materials

Abstract: TP53 mutations in formalin fixed paraffin embedded primary and metastatic prostate tumors stratified by immunohistochemistry (IHC) result. Bolded results indicate discordant samples. Red font indicates disruptive mutations by Poeta et al criteria (reference 42).

DOI: 10.1158/1078-0432.22463331.v1

Authors: Liana B. Guedes, Fawaz Almutairi, Michael C. Haffner, Gaurav Rajoria, Zach Liu, Szczepan Klimek, Roberto Zoino, Kasra Yousefi, Rajni Sharma, Angelo M. De Marzo, George J. Netto, William B. Isaacs, Ashley E. Ross, Edward M. Schaeffer, Tamara L. Lotan

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361921394

Cites:

Cited by:

Related to: 10